CARLI DICIOCCIO: Open Payments
NPI 1669832176 · DELRAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,652 in 96 payments from 17 companies in 2025. Trend: 2023 $1,907 · 2024 $956 · 2025 $1,652
Food & beverage: $1,587Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $378 |
| UCB, Inc. | 16 | $317 |
| Novartis Pharmaceuticals Corporation | 13 | $181 |
| Janssen Biotech, Inc. | 6 | $146 |
| GENZYME CORPORATION | 6 | $112 |
| Lilly USA, LLC | 6 | $90 |
| LEO Pharma Inc. | 5 | $77 |
| Galderma Laboratories, L.P. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $46 |
Products named: Bimzelx, SKYRIZI, TREMFYA, COSENTYX, DUPIXENT, RINVOQ, TALTZ, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
